Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sickle cell disease
Biotech
CRISPR Therapeutics laid off staff a week after positive AdComm
CRISPR Therapeutics laid off staff earlier this month despite being on the precipice of an FDA approval and having $1.7 billion in cash on hand.
Max Bayer
Nov 22, 2023 1:36pm
Sickle cell gene therapy process may cause cancerous mutations
Nov 20, 2023 9:10am
Gene editing biotech Graphite merges into vision loss biotech
Nov 15, 2023 9:57am
AstraZeneca pays $185M to reenter obesity race, drops SCD drug
Nov 9, 2023 5:00am
FDA advisers wave through first CRISPR-based therapy
Nov 1, 2023 11:07am
Beam lays off 20% of staff and culls CAR-T work to save cash
Oct 19, 2023 11:00am